Journey Medical Corporation
DERM
$6.07
-$0.11-1.78%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.59M | -11.43M | -8.66M | -8.74M | -8.30M |
| Total Depreciation and Amortization | 4.41M | 4.35M | 4.26M | 4.01M | 3.77M |
| Total Amortization of Deferred Charges | 461.00K | 466.00K | 442.00K | 406.00K | 346.00K |
| Total Other Non-Cash Items | 5.58M | 6.08M | 5.41M | 4.67M | 5.60M |
| Change in Net Operating Assets | -7.56M | -11.90M | -5.39M | -3.06M | -8.34M |
| Cash from Operations | -6.70M | -12.44M | -3.93M | -2.71M | -6.94M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -15.00M | -15.00M | -15.00M |
| Cash from Investing | -- | -- | -15.00M | -15.00M | -15.00M |
| Total Debt Issued | -- | -- | 5.05M | 5.00M | 10.00M |
| Total Debt Repaid | 0.00 | -625.00K | -1.25M | -1.88M | -1.88M |
| Issuance of Common Stock | 12.92M | 16.93M | 17.74M | 11.01M | 10.88M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -75.00K | -75.00K | -125.00K | -50.00K | -50.00K |
| Cash from Financing | 12.85M | 16.23M | 21.42M | 14.09M | 18.95M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.15M | 3.79M | 2.49M | -3.62M | -2.99M |